N
Novarex Co Ltd
KOSDAQ:194700
Novarex Co Ltd
KOSDAQ:194700
Price:
12 860
KRW
-7.01%
Market Cap:
₩241.1B
Balance Sheet
Balance Sheet Decomposition
Novarex Co Ltd
Novarex Co Ltd
Balance Sheet Decomposition is not available for
Novarex Co Ltd
Novarex Co Ltd
Balance Sheet
Novarex Co Ltd
Novarex Co Ltd
Currency: KRW
| Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
15 305
|
17 871
|
21 722
|
35 595
|
29 523
|
31 860
|
19 169
|
27 020
|
|
| Cash |
1 824
|
1 848
|
3
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
13 481
|
16 023
|
21 719
|
35 595
|
29 523
|
31 860
|
19 169
|
27 020
|
|
| Short-Term Investments |
287
|
449
|
560
|
463
|
51
|
4 376
|
32
|
12 625
|
|
| Total Receivables |
11 132
|
10 469
|
13 861
|
14 150
|
24 162
|
31 533
|
44 363
|
39 241
|
|
| Accounts Receivables |
11 093
|
10 412
|
13 792
|
14 150
|
23 891
|
31 329
|
43 226
|
37 357
|
|
| Other Receivables |
39
|
57
|
69
|
0
|
271
|
204
|
1 137
|
1 884
|
|
| Inventory |
10 386
|
8 866
|
8 732
|
13 210
|
25 580
|
30 865
|
46 501
|
49 816
|
|
| Other Current Assets |
1 714
|
2 780
|
730
|
558
|
683
|
1 432
|
1 588
|
764
|
|
| Total Current Assets |
38 824
|
40 436
|
45 605
|
63 975
|
79 999
|
100 066
|
111 653
|
129 465
|
|
| PP&E Net |
15 201
|
17 278
|
23 018
|
31 065
|
60 744
|
99 591
|
125 222
|
128 023
|
|
| PP&E Gross |
15 201
|
17 278
|
23 018
|
0
|
60 744
|
99 591
|
125 222
|
128 023
|
|
| Accumulated Depreciation |
3 549
|
4 744
|
6 196
|
0
|
9 477
|
12 401
|
17 237
|
23 883
|
|
| Intangible Assets |
499
|
642
|
1 184
|
1 321
|
1 518
|
1 988
|
2 806
|
2 937
|
|
| Note Receivable |
39
|
83
|
38
|
0
|
100
|
24
|
382
|
542
|
|
| Long-Term Investments |
323
|
571
|
836
|
4 948
|
3 860
|
7 190
|
8 285
|
3 477
|
|
| Other Long-Term Assets |
1 350
|
1 197
|
1 118
|
5 012
|
8 152
|
6 642
|
6 285
|
6 137
|
|
| Total Assets |
56 237
N/A
|
60 207
+7%
|
71 798
+19%
|
106 321
+48%
|
154 372
+45%
|
215 501
+40%
|
254 633
+18%
|
270 581
+6%
|
|
| Liabilities | |||||||||
| Accounts Payable |
14 710
|
10 920
|
14 263
|
14 739
|
20 702
|
21 296
|
39 282
|
29 598
|
|
| Accrued Liabilities |
847
|
1 705
|
2 005
|
0
|
2 443
|
2 588
|
3 517
|
3 947
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
15 000
|
15 000
|
15 000
|
|
| Current Portion of Long-Term Debt |
80
|
0
|
0
|
0
|
541
|
526
|
17 236
|
16 311
|
|
| Other Current Liabilities |
3 306
|
1 982
|
2 392
|
11 295
|
15 176
|
18 351
|
14 409
|
7 668
|
|
| Total Current Liabilities |
18 944
|
14 607
|
18 660
|
26 034
|
38 862
|
57 761
|
89 443
|
72 524
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
21 165
|
39 736
|
22 584
|
14 910
|
|
| Minority Interest |
0
|
141
|
462
|
162
|
85
|
380
|
291
|
247
|
|
| Other Liabilities |
985
|
842
|
801
|
1 199
|
2 471
|
2 015
|
2 647
|
1 780
|
|
| Total Liabilities |
19 929
N/A
|
15 590
-22%
|
19 922
+28%
|
27 396
+38%
|
62 582
+128%
|
99 891
+60%
|
114 965
+15%
|
89 461
-22%
|
|
| Equity | |||||||||
| Common Stock |
3 817
|
3 817
|
3 824
|
4 502
|
4 502
|
4 502
|
4 502
|
9 377
|
|
| Retained Earnings |
20 427
|
28 444
|
35 516
|
42 493
|
55 322
|
78 795
|
102 853
|
122 097
|
|
| Additional Paid In Capital |
11 579
|
11 579
|
11 678
|
31 997
|
31 997
|
31 997
|
31 997
|
49 330
|
|
| Other Equity |
484
|
777
|
859
|
66
|
30
|
316
|
316
|
316
|
|
| Total Equity |
36 308
N/A
|
44 617
+23%
|
51 876
+16%
|
78 925
+52%
|
91 791
+16%
|
115 609
+26%
|
139 668
+21%
|
181 120
+30%
|
|
| Total Liabilities & Equity |
56 237
N/A
|
60 207
+7%
|
71 798
+19%
|
106 321
+48%
|
154 372
+45%
|
215 501
+40%
|
254 633
+18%
|
270 581
+6%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
8
|
8
|
8
|
8
|
8
|
8
|
16
|
18
|
|
Switch to:
Switch to:
See Also
Discover More
